Resmed (RMD) Invested Capital (2010 - 2026)

Resmed (RMD) has 17 years of Invested Capital data on file, last reported at $259.9 million in Q1 2026.

• Quarterly Invested Capital rose 2523.95% year-over-year to $259.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $789.6 million (up 1893.62% YoY) and the FY2025 annual result came in at $9.9 million, changed 0.0% from the prior year.
• Invested Capital steadied at $259.9 million in Q1 2026, from $259.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $259.9 million in Q1 2026 to a low of $9.9 million in Q3 2024.
• A 5-year average of $54.1 million and a median of $9.9 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital sank 98.76% — and 2025, when it jumped 2526.3%.
• Tracing RMD's Invested Capital over 5 years: stood at $9.9 million in 2022, then retreated by 0.02% to $9.9 million in 2023, then climbed by 0.08% to $9.9 million in 2024, then jumped by 2523.72% to $259.9 million in 2025, then climbed by 0.01% to $259.9 million in 2026.
• The last three Invested Capital figures came in at $259.9 million (Q1 2026), $259.9 million (Q4 2025), and $259.9 million (Q3 2025), per Business Quant data.